Clinical trial
Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients…
NCT03955172 · Hospices Civils de Lyon, Other · Recruiting
Key facts
| NCT number | NCT03955172 |
|---|---|
| Title | Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection |
| Official title | Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced Natural Killer Cells Mediated (NK-mediated) Rejection |
| Acronym | STARR |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Recruiting |
| Study type | Interventional |
| Conditions | Kidney Transplant Failure and Rejection |
| Intervention type | Drug |
| Interventions | Everolimus |
| Enrollment | 20 |
| Start date | Dec 3, 2020 |
| Primary completion | Dec 3, 2027 |
| Completion | Dec 3, 2027 |
| First posted | May 20, 2019 |
| Last update posted | Jun 6, 2024 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: